Attaching-type heart function monitoring and/or intervening system

Abstract

The invention discloses an attaching-type heart function monitoring and / or intervening system. The attaching-type heart function monitoring and / or intervening system comprises a heart support device and a heart function monitoring device and / or intervening device, wherein the heart support device covers the outer surface of the heart ventricle and / or the heart atrium or attaches to the inner surface of the heat in a supporting manner, the heart function monitoring device is connected with a physiological and biochemical sensor, the physiological and biochemical sensor detects or senses the change of the physiological and biochemical parameters on the inner surface or the outer surface of the heart, and transmits the information to the heart function monitoring device through the wireless technology or the wired technology; the intervening device is selected from one or more of a pressure intervening device, an electric / magnetic stimulation intervening device and a medicine intervening device. With the system, the direct and accurate monitoring for the physiological and biochemical functional indexes of the local intracardiac / extracardiac membrane and the direct and accurate specific drug delivery for the local intracardiac / extracardiac membrane or the electric / magnetic stimulation or heart ventricle pressure regulation can be realized, monitoring and treatment are organically combined, and thus the heart failure state of patients can be improved.

Description

technical field [0001] The invention belongs to the field of medical equipment, and in particular relates to a device for monitoring and treating various types of heart diseases after being implanted on the outer surface of the heart or in the heart cavity, and is especially suitable for the diagnosis and treatment of heart failure or various myocardial diseases. At the same time, it can also be applied to the treatment and diagnosis of lung, kidney, liver, spleen, stomach, bladder and other organ diseases. Background technique [0002] Heart failure is a common pathophysiological state in which most heart lesions develop to the end stage. It is a clinical syndrome of impaired ventricular filling or ejection ability caused by cardiac structure and dysfunction. Its basic manifestations are dyspnea and fatigue, exercise tolerance Restricted, fluid retention can also occur and can lead to pulmonary congestion and peripheral edema. [0003] Although some progress has been made ...

AI Technical Summary

Problems solved by technology

[0010] 1. Passivity of treatment regulation: neither CSD nor Heartnet can carry out active clinical intervention. Once implanted in the body during treatment, it is difficult to adjust and control. Carry out quantitative, timing, real-time, anytime, and timely artificial regulation;

[0011] 2. Unity of treatment methods: LVAD, CSD, Heartnet, and QVR have obvious singleness in treatment, and can no longer be organically combined with other medical methods, especially direct drug intervention or electrical stimulation. Adequate, effective and straightforward combination of effective drug treatments;

However, LVAD, CSD, Heartnet, QVR and other devices have no effective methods to directly and organically combine themselves with the above-mentioned various treatment methods or technologies conveniently, quickly and economically.

Therefore, the clinical efficacy and application potential of the current main heart failure treatment devices such as LVAD, CSD, Heartnet, and QVR are limited.

Images